- Raw materials
- Additives
- Solvents
- Desulfo-Coenzyme A
Desulfo-Coenzyme A API Manufacturers & Suppliers
0 verified results
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Commercial-scale Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Desulfo-coenzyme A | CAS No: 5863-40-1 | GMP-certified suppliers
A medication that serves as an experimental coenzyme involved in nucleotide metabolism, useful for biochemical and pharmaceutical research applications in enzyme cofactor function studies.
Therapeutic categories
Product Snapshot
- Desulfo-coenzyme A is an oral small molecule formulation
- It is primarily used in experimental applications related to metabolic and enzymatic disorders
- The compound is currently in the experimental stage and has no approved regulatory status in major markets such as FDA or EMA
Clinical Overview
Currently, desulfo-coenzyme A does not have established clinical indications or approved therapeutic uses. It is primarily of interest within biochemical and pharmaceutical research contexts rather than as a marketed pharmaceutical agent. As an experimental compound, it lacks comprehensive pharmacodynamics and mechanism of action data.
Although specific pharmacokinetic (absorption, distribution, metabolism, and excretion) properties have not been characterized for desulfo-coenzyme A, related coenzymes generally exhibit intracellular activity and involvement in metabolic processes. The absence of detailed ADME data necessitates cautious interpretation regarding systemic exposure and bioavailability.
Safety and toxicity profiles for desulfo-coenzyme A remain uncharacterized due to its experimental status. No regulatory approvals or formal safety evaluations have been documented, limiting its current use to controlled laboratory research.
There are no notable commercial brands associated with desulfo-coenzyme A, reflecting its investigational status. The compound’s chemical classification points towards a role in nucleotide biochemistry and enzyme cofactor activity, which could inform ongoing research but does not imply clinical application.
For sourcing and quality control, procurement of desulfo-coenzyme A as an active pharmaceutical ingredient should prioritize suppliers with validated chemical synthesis methods and stringent quality assurance protocols. Because the compound is experimental and not commercially marketed, verification of purity, identity, and consistency is critical. Analytical characterization should include confirmation of molecular structure, assay of related impurities, and compliance with applicable regulatory standards for research-grade materials.
Identification & chemistry
| Generic name | Desulfo-coenzyme A |
|---|---|
| Molecule type | Small molecule |
| CAS | 5863-40-1 |
| DrugBank ID | DB01829 |
Pharmacology
Targets
| Target | Organism | Actions |
|---|---|---|
| Chloramphenicol acetyltransferase | Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228) |
Formulation & handling
- Desulfo-coenzyme A is a small molecule suitable for oral administration due to its solid state and low logP value indicating high hydrophilicity.
- The compound's high molecular weight and experimental status warrant thorough stability and compatibility assessments during formulation development.
- Its strong hydrophilic nature suggests potential challenges in membrane permeability, which may require specialized drug delivery strategies.
Regulatory status
Desulfo-Coenzyme A is a type of Solvents
Solvents play a crucial role in the pharmaceutical industry as a subcategory of active pharmaceutical ingredients (APIs). These chemical compounds are employed for various purposes, including the extraction, purification, and formulation of drugs. Solvents are utilized in the production of pharmaceutical APIs to dissolve, suspend, or extract the desired substances from raw materials.
Pharmaceutical solvents possess specific characteristics that make them suitable for their intended applications. They exhibit high purity levels and low impurity profiles, ensuring the safety and efficacy of the final pharmaceutical products. Solvents are selected based on factors such as their ability to dissolve the API, compatibility with other ingredients, and regulatory compliance.
Common solvents used in the pharmaceutical industry include ethanol, methanol, acetone, and ethyl acetate. These solvents are known for their favorable properties such as high solvency power, volatility, and stability. However, the selection of a solvent depends on the specific requirements of the API and the manufacturing process.
It is crucial to ensure that solvents used in pharmaceutical manufacturing are of pharmaceutical grade and meet stringent quality standards. This guarantees the absence of impurities that could potentially affect the safety and efficacy of the pharmaceutical products. Regulatory authorities, such as the FDA, have established guidelines and specifications for pharmaceutical solvents to ensure their quality and safety.
In conclusion, solvents are an integral part of the pharmaceutical API subcategory. Their precise selection and utilization enable the extraction, purification, and formulation of drugs. The pharmaceutical industry relies on high-quality solvents to ensure the production of safe and effective medications.
Desulfo-Coenzyme A (Solvents), classified under Additives
Additives in the pharmaceutical API category refer to a group of chemical substances that are incorporated into pharmaceutical products to enhance their stability, functionality, or performance. These additives play a crucial role in ensuring the quality, safety, and efficacy of medications.
One common type of additive used in pharmaceuticals is preservatives. Preservatives are added to prevent microbial growth and maintain the integrity of the product throughout its shelf life. They help to safeguard against contamination and maintain the potency of the active pharmaceutical ingredient (API). Some commonly used preservatives include benzyl alcohol, phenol, and parabens.
Another important group of additives is antioxidants. Antioxidants are added to pharmaceutical formulations to prevent or delay the oxidation of APIs, which can lead to degradation and loss of potency. Examples of antioxidants commonly used in pharmaceuticals include ascorbic acid (vitamin C) and tocopherols (vitamin E).
In addition to preservatives and antioxidants, other additives like flavorings, colorants, and sweeteners may be incorporated into pharmaceutical products to improve their palatability and patient acceptability.
It is crucial to note that the use of additives in pharmaceuticals is strictly regulated by health authorities to ensure their safety and efficacy. Manufacturers must comply with stringent quality control standards and guidelines to guarantee the proper use and appropriate levels of additives in pharmaceutical products.
Overall, additives play a vital role in the pharmaceutical industry by enhancing the stability, functionality, and patient acceptability of medications. Their careful selection and incorporation contribute to the overall quality and effectiveness of pharmaceutical products.
